4D Molecular Therapeutics Cash Flow Statement (2019-2026) | FDMT

Cash Flow Statement Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026
Operating Activities
Net Income (Quarter)
-7.59M-22.23M-25.08M-26.29M-28.09M-25.70M-27.38M-28.66M-29.62M-10.10M-32.27M-32.39M-34.91M-43.84M-49.65M-48.04M-54.60M-56.85M19.42M-68.76M
Depreciation and Depletion (Quarter)
0.40M0.40M0.40M0.40M0.50M0.50M1.00M1.00M1.10M1.10M1.30M1.20M1.20M1.20M1.20M1.30M1.30M1.30M1.30M1.30M
Share-based Compensation (Quarter)
3.82M3.92M3.73M3.93M4.32M4.52M4.35M4.22M4.97M4.56M5.91M5.97M6.07M6.49M7.58M6.99M4.96M4.52M5.55M4.45M
Gains from Sales and Divestitures (Quarter)
0.01M0.02M0.03M0.05M0.02M0.07M0.11M0.16M0.05M
Gains from Investment Securities (Quarter)
0.03M0.09M3.07M0.30M-0.44M0.11M0.27M6.02M0.00M0.09M0.18M0.22M9.41M2.78M10.45M1.87M-0.19M0.67M
Non-cash Items (Quarter)
1.36M1.38M24.67M1.70M2.01M2.28M48.05M2.61M2.94M3.15M46.86M3.32M3.73M4.14M0.34M4.97M5.49M6.02M5.73M5.59M
Cash from Operations (Quarter)
-16.20M-15.72M-21.84M-23.55M-19.90M-21.02M-22.21M-27.91M-22.07M-1.17M-24.65M-29.09M-30.24M-29.39M-45.86M-47.76M-43.38M-46.50M28.55M-68.12M
Depreciation, Depletion & Amortization
Amortizatization of Intangibles (Quarter)
0.37M0.38M-1.84M0.38M0.36M-2.03M2.77M0.40M0.34M0.40M0.41M0.76M0.09M0.51M0.69M1.27M1.17M1.15M1.15M1.13M
Depreciation & Amortization (CF) (Quarter)
0.37M0.38M0.39M0.41M0.47M0.52M1.01M1.03M1.08M0.99M1.10M1.17M1.19M1.19M1.10M1.05M1.17M1.26M1.22M1.27M
Change in Working Capital
Change in Receivables (Quarter)
0.25M-0.43M-0.74M-0.05M
Change in Account Payables (Quarter)
0.43M0.80M1.66M-1.68M0.23M-1.70M1.51M-0.33M0.95M1.37M-1.09M0.70M-0.79M-0.51M1.46M-0.23M4.55M-1.84M4.30M3.53M
Change in Accured Expenses (Quarter)
0.55M1.06M0.54M-1.07M0.65M1.08M1.82M-3.40M1.16M3.61M2.00M-2.39M3.17M8.11M-2.37M-2.31M3.11M4.98M2.37M-4.12M
Investing Activities
Capital Expenditures (Quarter)
-0.29M0.96M0.90M0.26M1.04M-1.00M0.64M0.36M1.46M-1.47M2.43M0.71M-0.53M2.66M-2.33M0.14M0.56M-0.09M-0.61M
Change in Acquisitions & Divestments (Quarter)
5.00M12.00M65.72M205.28M-135.19M58.87M55.52M30.39M28.51M14.78M23.57M64.87M65.79M166.66M101.62M32.93M49.18M102.40M
Cash from Investing Activities (Quarter)
-0.74M-139.01M-32.29M-54.11M57.47M15.37M-35.78M43.13M49.29M29.98M-6.68M-263.26M-73.54M27.30M7.06M31.95M-13.85M17.78M-128.85M68.89M
Financing Activities
Other financing activities (Quarter)
-0.95M0.25M0.11M-0.36M0.47M0.07M0.26M
Change in Capital Stock
Shares Issued (Quarter)
114.30M0.88M-0.88M1.42M8.23M9.49M0.00M34.90M-19.64M0.04M9.70M
Preferred Shares Issued (Quarter)
Misc.
Cash from Financing Activities (Quarter)
0.82M1.98M116.14M0.63M-0.05M0.46M2.05M10.99M130.52M10.56M4.76M318.83M17.25M0.57M0.60M0.86M0.12M111.98M11.48M
Change in Cash (Quarter)
-16.12M-152.75M62.01M-77.03M37.51M-5.19M-55.95M26.22M157.74M39.37M-26.57M26.49M-86.53M-1.52M-38.20M-15.81M-56.37M-28.60M11.69M12.25M
Free Cash Flow (Quarter)
-15.91M-16.68M-22.73M-23.81M-20.95M-20.02M-22.85M-28.26M-23.52M0.30M-27.08M-29.80M-29.71M-32.05M-43.53M-47.90M-43.93M-46.41M29.16M-68.12M
Net Cash Flow (Quarter)
-16.12M-152.75M62.01M-77.03M37.51M-5.19M-55.95M26.22M157.74M39.37M-26.57M26.49M-86.53M-1.52M-38.20M-15.81M-56.37M-28.60M11.69M12.25M